Cargando…

Commentary: Proinflammatory role of blister fluid-derived exosomes in bullous pemphigoid

Detalles Bibliográficos
Autores principales:	Liu, Yangchun, Li, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378439/ https://www.ncbi.nlm.nih.gov/pubmed/32765519 http://dx.doi.org/10.3389/fimmu.2020.01506

Ejemplares similares

Blister Fluid Induces MMP-9-Associated M2-Type Macrophages in Bullous Pemphigoid
por: Riani, Meriem, et al.
Publicado: (2019)

Proinflammatory Cytokine Gene Polymorphisms in Bullous Pemphigoid
por: Tabatabaei-Panah, Pardis-Sadat, et al.
Publicado: (2019)

Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid
por: Leighty, Lisa, et al.
Publicado: (2007)

Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
por: Wang, Si-Hang, et al.
Publicado: (2021)

Pilot study investigating BP-180 in extracellular vesicles derived from blister fluid of bullous pemphigoid patients
por: Gasparini, Giulia, et al.
Publicado: (2023)

The Diagnosis and Blistering Mechanisms of Mucous Membrane Pemphigoid
por: Kamaguchi, Mayumi, et al.
Publicado: (2019)

Biological treatment for bullous pemphigoid
por: Oren-Shabtai, Meital, et al.
Publicado: (2023)

IL-13 Genetic Susceptibility to Bullous Pemphigoid: A Potential Target for Treatment and a Prognostic Marker
por: Wang, Yiman, et al.
Publicado: (2022)

Elevated levels of interleukin-9 in the serum of bullous pemphigoid: possible association with the pathogenicity of bullous pemphigoid
por: Koga, Hiroshi, et al.
Publicado: (2023)

BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid
por: Liu, Yale, et al.
Publicado: (2017)

Biochip detection of BP180 autoantibodies in blister fluid for the serodiagnosis of bullous pemphigoid: A pilot study
por: Sernicola, Alvise, et al.
Publicado: (2019)

Evaluation of ELISA BP180 and BP230 Autoantibodies in Blister Fluid and Serum in the Diagnosis of Bullous Pemphigoid
por: Nagarajan, Harish, et al.
Publicado: (2023)

Localized bullous pemphigoid: a case report
por: Wang, Yiman, et al.
Publicado: (2020)

Regulatory T Cells Suppress Inflammation and Blistering in Pemphigoid Diseases
por: Bieber, Katja, et al.
Publicado: (2017)

Diminished Expression of Galectin-3 Around Blisters in Bullous Pemphigoid: An Immunohistochemistry Study
por: Aghighi, Maryam, et al.
Publicado: (2020)

Spongiotic Intra-Epidermal Blister: A Pitfall in the Histopathologic Diagnosis of Bullous Pemphigoid
por: Joshi, Rajiv
Publicado: (2013)

Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination
por: Tomayko, Mary M., et al.
Publicado: (2021)

Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms
por: Cole, Connor, et al.
Publicado: (2022)

Case Report: The many faces of bullous pemphigoid
por: Rechtien, Laura, et al.
Publicado: (2023)

Blisters and Milia around the Peritoneal Dialysis Catheter: A Case of Localized Bullous Pemphigoid
por: Michelerio, Andrea, et al.
Publicado: (2022)

Lichen Planus Pemphigoides: From Lichenoid Inflammation to Autoantibody-Mediated Blistering
por: Hübner, Franziska, et al.
Publicado: (2019)

Assessment of the Characteristics and Associated Factors of Infectious Complications in Bullous Pemphigoid
por: Chen, Jia, et al.
Publicado: (2020)

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
por: Tasanen, Kaisa, et al.
Publicado: (2019)

New Insights Into the Pathogenesis of Bullous Pemphigoid: 2019 Update
por: Genovese, Giovanni, et al.
Publicado: (2019)

Polymorphisms in the Mitochondrial Genome Are Associated With Bullous Pemphigoid in Germans
por: Russlies, Juliane, et al.
Publicado: (2019)

Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
por: Zhang, Yihua, et al.
Publicado: (2021)

Emerging Biomarkers and Therapeutic Strategies for Refractory Bullous Pemphigoid
por: Zhou, Tong, et al.
Publicado: (2021)

Worldwide epidemiologic factors in pemphigus vulgaris and bullous pemphigoid
por: Rosi-Schumacher, Mattie, et al.
Publicado: (2023)

Comorbidity in bullous pemphigoid: up-date and clinical implications
por: Huttelmaier, Johanna, et al.
Publicado: (2023)

The Autoimmune Skin Disease Bullous Pemphigoid: The Role of Mast Cells in Autoantibody-Induced Tissue Injury
por: Fang, Hui, et al.
Publicado: (2018)

Bullous pemphigoid
por: Miyamoto, Denise, et al.
Publicado: (2019)

The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid
por: Messingham, Kelly N., et al.
Publicado: (2019)

Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid
por: Seyed Jafari, S. Morteza, et al.
Publicado: (2021)

Paradoxical phenomena of bullous pemphigoid induced and treated by identical biologics
por: Zhang, Jie, et al.
Publicado: (2023)

Adaptive and innate immune pathogenesis of bullous pemphigoid: A review
por: Yan, Tianmeng, et al.
Publicado: (2023)

Bullous pemphigoid: The role of type 2 inflammation in its pathogenesis and the prospect of targeted therapy
por: Zhang, Luyao, et al.
Publicado: (2023)

Two infants with blistering rashes originating on acral sites as a presenting sign of infantile bullous pemphigoid
por: Folsom, Brent, et al.
Publicado: (2020)

Bullous Pemphigoid and Other Pemphigoid Dermatoses
por: Pratasava, Valeryia, et al.
Publicado: (2021)

Case Report: A Rare Case of Pembrolizumab-Induced Bullous Pemphigoid
por: Zhang, Xiaoyan, et al.
Publicado: (2021)

Effect of early initiation of steroid-sparing drugs in patients with bullous pemphigoid
por: Fenne, Inger Johanne, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_knapl7nu5eupvuoh26u0qntb9p